cJun NH 2 -terminal kinase (JNK) inhibition has been suggested as a potential treatment for 44 insulin resistance and steatosis through activation of the transcription factor PPAR.
INTRODUCTION

61
Liver cancer is the fifth most common cancer and the second leading cause of cancer 62 deaths worldwide (El-Serag, Davila et al., 2003 , Parkin, Bray et al., 2005 . Metabolic and is a major regulator of fatty acid transport, catabolism and energy homeostasis 86 (Memon, Tecott et al., 2000) . PPAR activation in the liver is increased in metabolic 87 diseases and obesity (Memon et al., 2000) , and PPAR agonists appear to be 88 therapeutically beneficial in diabetes. In fact, PPAR protects against steatosis in the 
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The activation of PPAR modifies bile acid (BA) synthesis, conjugation and transport (Li & 98 Chiang, 2009 ). Altered regulation of BA may protect against steatosis but could increase 99 liver cancer development due to changes in FGF protein levels. Although FGF19 improves 100 the glycemic response and reduces liver steatosis, it also induces liver cancer (Shapiro, did not indicate the presence of liver pathology ( Figure EV1C ). However, at age 10 135 months, 82% of L DKO mice displayed multifocal bile duct hyperplasia together with fibrosis 136 and inflammatory cell infiltrates ( Fig 1D) . Cholangiocytes stained positively with PCNA, a 137 marker for proliferation ( Fig 1D) . These changes were associated with increased 138 expression of myeloid genes (Cd68 and Lyz) and inflammatory cytokines (Ifng, Tnf, Il10, 139 and Il12a) in the liver ( Fig 1E) , and increased liver damage, as suggested by the high 140 levels of liver enzymes (ALT, AST, and -GT) in the blood of L DKO mice ( Fig 1F) . The 141 remaining L DKO mice exhibited cholangiocarcinoma (6%) or appeared to be healthy (12%).
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At age 14 months, 95% of L DKO mice displayed cholangiocarcinoma (Fig 2A) associated 143 with fibrosis ( Fig 2B) and a large increase in liver mass together with a significant increase 144 in ALT and AST ( Fig 2C) . The remaining L DKO mice (6%) exhibited cystic livers with bile 145 duct hyperplasia. Histological analysis indicated increased staining of glutamine 146 synthetase (GS) in liver tumor lesions, together with neoplastic nodules with positive 147 staining of the ductular markers CK19 and Sox9 ( Fig 2D) . Together, these data confirm 
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Notch receptor ligand Jagged-1 promotes the formation of intrahepatic bile ducts (Piccoli & 156 Spinner, 2001) , and was overexpressed in the liver of L DKO mice ( Fig 2E) . Moreover, Bone hepatoblasts (Yanai, Tatsumi et al., 2008) ; expression of hepatic Bmp4 was increased in 160 L DKO mice compared with L WT mice ( Fig 2E) . Hepatoblasts maturate to cholangiocytes 161 through activation of ERK pathway (Yang, Wang et al., 2017) and BA can increase 162 proliferation by ERK activation through FXR/FGF15/FGR4 pathway (Li & Chiang, 2015) .
163
We evaluated this pathway in 6 months-old mice, before cancer has developed. In 164 concordance with elevated BA production, we found high FXR activation as suggested by 165 the high levels of its target genes (Shp and Fgr4) observed in L DKO mice ( Fig 2F) .
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Moreover, while control mice did not expressed Fgf15, we could detect Fgf15 in L DKO livers 167 ( Fig 2F) . In agreement with these results, histological analysis indicated increased staining 
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To confirm that hyperactivation of PPAR is involved in the development of 175 cholangiocarcinoma in L DKO mice, we ablated the Ppara gene in L DKO mice. In the resulting 176 JNK1/2 plus PPAR liver-deficient-mice (L PPARαDKO ), both tumor burden and incidence 177 were clearly reduced ( Fig 3A) compared with L DKO mice. The major changes in BA were 178 also reversed ( Fig 3B) . This is consistent with reduced hepatic expression in L PPARαDKO 179 mice of genes involved in cholesterol and BA synthesis (Hmgcr, Baat, Cyp8b1 and 180 Cyp27a) and hepatocyte-mediated BA transport (Abc11, Abc4, Abcg5, Abcg8) ( Fig 3C) .
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Histological analyses indicated that PPAR deficiency increased liver steatosis, but 182 reduced hallmarks of carcinogenesis (anisokaryosis, apoptosis, ductogenesis, dysplasia 183 and mitosis) in L PPARαDKO compared with L DKO mice ( Fig 3D) . Moreover, CK19 and SOX9 staining were increased in L DKO mice compared with L PPARαDKO in agreement with 185 cholangiocyte proliferation. Furthermore, although liver tumor lesions in L DKO mice became 186 prominently stained for glutamine synthetase (GS), reduced staining for glutamine 187 synthetase was observed in the liver of L PPARαDKO mice ( Fig 3D) . In addition, RT-qPCR 188 analysis indicated that both inflammation and cholangiocarcinoma markers were reduced 189 in L PPARαDKO mice compared with L DKO mice ( Fig 3E, F) . This evidence suggests that 
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Recently, it has been shown that increased hepatic BA controls HCC development in HFD- Fig 4A) . On normal chow diet, the two genotypes showed no 208 significant differences in tumor number or size (Figu EV2). In contrast, on HFD, the mean number of tumors per animal was lower in PPARKO mice compared with WT 210 counterparts ( Fig 4B) . Moreover, tumors were smaller in PPARKO mice than in WT mice 211 ( Fig 4B) . This protection against HCC development in HFD-fed PPARKO mice explained 212 the better survival ( Fig 4C) . RT-qPCR analysis of tumor and non-tumor tissues from WT 
229
However, there was no significant reduction in blood levels of the cytokines IL6, TNF, 230 IL1, CCL2, and IFN in HFD-fed PPARKO mice, suggesting that the lower acute DEN-231 induced liver damage was not associated with reduced inflammation ( Fig EV3) . After acute 232 DEN injection, HFD-fed PPARKO mice showed higher levels of the chemokines CXCL2 233 and CCL3 ( Fig EV3) , correlating with higher levels of markers of infiltration by immune cells ( Fig EV4) . These results suggest that PPAR in the liver, and not in hematopoietic 235 cells, promotes HCC development in HFD-fed WT animals.
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To confirm the role of PPAR in hepatocytes, we tested HCC development in chimeras 
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A L WT and L DKO mice at 6 months of age were fasted overnight and blood was collected.
634
The amount of bile acids in the blood was measured (mean ± SEM; n = 6-11). Statistically 635 significant differences between L DKO and L WT are indicated (**, P < 0.01). A Representative livers, tumor burden and incidence in 11 month old L WT , L DKO and 680 L PPARDKO mice (mean ± SEM; n = 14-25).
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B The amount of bile acid in the blood was measured (mean ± SE; n = 7-11). The 
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Data are shown as means ± SEM (n = 4-6). Statistically significant differences between
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WT and PPARKO mice are indicated (*, P < 0.05; **, P < 0.01). 
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